Evolent Health Revenue 2014-2025 | EVH
Evolent Health revenue from 2014 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Evolent Health Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $2,555 |
| 2023 | $1,964 |
| 2022 | $1,352 |
| 2021 | $908 |
| 2020 | $925 |
| 2019 | $687 |
| 2018 | $627 |
| 2017 | $435 |
| 2016 | $254 |
| 2015 | $97 |
| 2014 | $0 |
| 2013 | $26 |
| Evolent Health Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $484 |
| 2024-12-31 | $647 |
| 2024-09-30 | $621 |
| 2024-06-30 | $647 |
| 2024-03-31 | $640 |
| 2023-12-31 | $556 |
| 2023-09-30 | $511 |
| 2023-06-30 | $469 |
| 2023-03-31 | $428 |
| 2022-12-31 | $382 |
| 2022-09-30 | $353 |
| 2022-06-30 | $320 |
| 2022-03-31 | $297 |
| 2021-12-31 | $248 |
| 2021-09-30 | $222 |
| 2021-06-30 | $222 |
| 2021-03-31 | $215 |
| 2020-12-31 | $247 |
| 2020-09-30 | $240 |
| 2020-06-30 | $217 |
| 2020-03-31 | $221 |
| 2019-12-31 | $77 |
| 2019-09-30 | $220 |
| 2019-06-30 | $192 |
| 2019-03-31 | $198 |
| 2018-12-31 | $193 |
| 2018-09-30 | $150 |
| 2018-06-30 | $144 |
| 2018-03-31 | $140 |
| 2017-12-31 | $114 |
| 2017-09-30 | $108 |
| 2017-06-30 | $107 |
| 2017-03-31 | $106 |
| 2016-12-31 | $88 |
| 2016-09-30 | $60 |
| 2016-06-30 | $57 |
| 2016-03-31 | $49 |
| 2015-12-31 | $46 |
| 2015-09-30 | $40 |
| 2015-06-30 | $10 |
| 2015-03-31 | |
| 2014-12-31 | $-20 |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | $20 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.105B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.937B | 59.72 |
| Hims & Hers Health (HIMS) | United States | $13.490B | 140.16 |
| Doximity (DOCS) | United States | $11.213B | 51.91 |
| Tempus AI (TEM) | United States | $10.091B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.366B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.822B | 59.72 |
| Hinge Health (HNGE) | United States | $3.402B | 0.00 |
| Privia Health (PRVA) | United States | $2.375B | 162.33 |
| 10x Genomics (TXG) | United States | $1.724B | 0.00 |
| Phreesia (PHR) | United States | $1.614B | 0.00 |
| Enovis (ENOV) | United States | $1.561B | 8.70 |
| Schrodinger (SDGR) | United States | $1.553B | 0.00 |
| Azenta (AZTA) | United States | $1.553B | 72.17 |
| Clover Health Investments (CLOV) | United States | $1.471B | 0.00 |
| Omnicell (OMCL) | United States | $1.387B | 24.48 |
| Claritev (CTEV) | United States | $0.635B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.535B | 0.00 |
| Standard BioTools (LAB) | United States | $0.528B | 0.00 |
| Veradigm (MDRX) | United States | $0.503B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.453B | 0.00 |
| Talkspace (TALK) | United States | $0.420B | 125.50 |
| TruBridge (TBRG) | United States | $0.328B | 728.00 |
| Outset Medical (OM) | United States | $0.311B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.273B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.255B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.218B | 0.00 |
| CapsoVision (CV) | United States | $0.210B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.182B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| American Well (AMWL) | United States | $0.129B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.100B | 3.82 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.079B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.078B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.042B | 0.00 |
| HeartBeam (BEAT) | United States | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |